Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Sector: Services-Commercial Physical & Biological Research
Industry: Medical - Diagnostics & Research
Medpace Holdings, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 27.97M shares outstanding
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services.
The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia.
Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Leadership
August J. Troendle
Chief Executive Officer and Chairman of the Board
Brian T. Carley
Director
Cornelius P. McCarthy III
Director
Dani S. Zander
Director
Employees
7K+
Country
US
Sector
Healthcare
Website
medpace.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Exec. VP, Operations | Option Exercise | 2.7K | $450.2K | Oct 21, 2026 | |
| Exec. VP, Operations | Option Exercise | 2.7K | -- | Oct 21, 2026 | |
| Exec. VP, Operations | Option Exercise | 3.0K | -- | Oct 12, 2026 | |
| Exec. VP, Operations | Option Exercise | 3.0K | $500.2K | Oct 12, 2026 | |
| Exec. VP, Operations | Option Exercise | 2.0K | $333.5K | Oct 7, 2026 | |
| Exec. VP, Operations | Option Exercise | 2.0K | -- | Oct 7, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
August J. Troendle · joint filing· may incl. warrants· filed Sep 2026 | 5.4M | 19.3% | 13D |
BlackRock, Inc. | 2.5M | 8.9% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jan 2024 | 2.4M | 8.6% | 13G |
PRICE T ROWE ASSOCIATES INC /MD/ | 2.1M | 7.4% | 13F |
AQR CAPITAL MANAGEMENT LLC | 1.3M | 4.6% | 13F |
Wasatch Advisors LP 87-0319391 · also on 13F· may incl. warrants· filed Feb 2024 | 1.2M | 4.2% | 13G |
VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | 4.1% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | 3.7% | 13F |
STATE STREET CORP | 710.9K | 2.5% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 710.5K | 2.5% | 13F |
Insiders
- BURWIG SUSAN EExec. VP, Operations
- Troendle August J.President & CEO
- Kraft Robert O.Director
- McCarthy Cornelius P. IIIDirector
- Carley Brian TDirector
- Brady Kevin M.CFO & Treasurer
- DAVENPORT FRED B JRDirector
- EWALD STEPHEN PGeneral Counsel & Corp. Secy.
- Gwadry-Sridhar Femida H.Director
- Zander Dani S.Director
based on 27.97M shares outstanding
30d Avg
336.42K
60d Avg
284.18K
90d Avg
272.51K